Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 915-782-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute Oral Toxicity (weight of evidence): LD50 > 2000 and < 5000 mg/kg bw, 2019
1. Acute Oral (Read-Across: 4-methyl-2-phenyltetrahydro-2H-pyran): LD50 > 2000 mg/kg bw, eq. or similar to EU Method B.1, 1992
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study performed under GLP. All relevant validity criteria were met.
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected: June 1990 ; signature: September 1990
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl:CD(SD)BR strain (VAF plus)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Recognised animal supplier
- Age at study initiation: 4-6 weeks
- Weight at study initiation: males 100-113g; females 109 - 116g
- Fasting period before study: overnight before dosing
- Housing: Animals were housed in groups of 5, by sex, in grid bottomed cages suspended over cardboard lined excreta trays. cardboard tray liners were changed as often as necessary to maintain hygiene.
- Diet (e.g. ad libitum): pelleted diet ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-21
- Humidity (%): 32-52
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12 hour dark / 12 hours light - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 mL/kg - Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 per sex dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were examined shortly after dosing and approximately 30 minutes, 1, 2 and 4 hours after dosing and daily thereafter for 14 consecutive days. On the day of dosing all animals were weighed in order to calculate the amount of test article to be administered. They were weighed again on day 8 and on day 15.
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One female was euthanasied on day 2 as death was considered to be inevitable. The remaining animals survived to the end of the study.
- Clinical signs:
- other: A hunched posture was seen in all females and most males from day 1, but by day 3 all surviving animals appeared to be outwardly healthy.
- Gross pathology:
- No significant findings that are not consistent with background macroscopic pathology of the strain.
- Interpretation of results:
- not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral median lethal dose (LD50) of the test substance in male and female Crl:CD(SD)BR strain (VAF plus) of rat was estimated to be greater than 2000 mg/kg body weight.
- Executive summary:
The study was performed according to a method equivalent to EU Method B.1 and/or OECD TG 401 guidelines in accordance with GLP. The test material was administered as a single oral dose, by gavage, at a dose level of 2000 mg/kg bodyweight to a group of 5 male and 5 female rats following an overnight fast. The animals were observed for 14 days and survivors were then euthanized. All animals were subject to necropsy. One female was humanely euthanized as death was considered to be inevitable; all remaining animals survived to the end of the study. Clinical signs of toxicity were noted in most animals on the day of dosing, but all surviving animals appeared outwardly healthy from day 3 onwards. There was no adverse effect on bodyweight gain in animals of either sex. Necropsy findings were of low incidence and are considered not to be significant. When administered as a single oral dose of 2000 mg/ kg bodyweight, the test material produced some evidence of toxicity in the rat. The LD50 for both sexes combined is estimated to be in excess of 2000 mg/kg.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1992
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline study performed under GLP. All relevant validity criteria were met.
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Further information is included in attachment to IUCLID section 13.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
The read-across is based on the hypothesis that the source and target substances have common structural features in the same relative positions. The source and target have similar physico-chemical, toxicological properties and because of common metabolism they share common or have similar breakdown products and therefore potential mechanisms of action. Further information is included in attachment to IUCLID section 13.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
The source and target chemicals have comparable chemical similarity. Further information is included in attachment to IUCLID section 13
3. ANALOGUE APPROACH JUSTIFICATION
The source substance is a chemically similar substance with common metabolism and common or similar degradants of the target substance. Further information is included in attachment to IUCLID section 13
4. DATA MATRIX
Further information is included in attachment to IUCLID section 13. - Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.1 (Acute Toxicity (Oral))
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected: June 1990 ; signature: September 1990
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl:CD(SD)BR strain (VAF plus)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Recognised animal supplier
- Age at study initiation: 4-6 weeks
- Weight at study initiation: males 100-113g; females 109 - 116g
- Fasting period before study: overnight before dosing
- Housing: Animals were housed in groups of 5, by sex, in grid bottomed cages suspended over cardboard lined excreta trays. cardboard tray liners were changed as often as necessary to maintain hygiene.
- Diet (e.g. ad libitum): pelleted diet ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-21
- Humidity (%): 32-52
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12 hour dark / 12 hours light - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Amount of vehicle (if gavage): 10 mL/kg - Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 per sex dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were examined shortly after dosing and approximately 30 minutes, 1, 2 and 4 hours after dosing and daily thereafter for 14 consecutive days. On the day of dosing all animals were weighed in order to calculate the amount of test article to be administered. They were weighed again on day 8 and on day 15.
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One female was euthanasied on day 2 as death was considered to be inevitable. The remaining animals survived to the end of the study.
- Clinical signs:
- other: A hunched posture was seen in all females and most males from day 1, but by day 3 all surviving animals appeared to be outwardly healthy.
- Gross pathology:
- No significant findings that are not consistent with background macroscopic pathology of the strain.
- Interpretation of results:
- not classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The target substance acute oral median lethal dose (LD50) in male and female Crl:CD(SD)BR strain (VAF plus) of rat is expected to be greater than 2000 mg/kg body weight.
- Executive summary:
The study was performed on a source substance according to a method equivalent to EU Method B.1 and/or OECD TG 401 guidelines in accordance with GLP. The test material was administered as a single oral dose, by gavage, at a dose level of 2000 mg/kg bodyweight to a group of 5 male and 5 female rats following an overnight fast. The animals were observed for 14 days and survivors were then euthanized. All animals were subject to necropsy. One female was humanely euthanized as death was considered to be inevitable; all remaining animals survived to the end of the study. Clinical signs of toxicity were noted in most animals on the day of dosing, but all surviving animals appeared outwardly healthy from day 3 onwards. There was no adverse effect on bodyweight gain in animals of either sex. Necropsy findings were of low incidence and are considered not to be significant. When administered as a single oral dose of 2000 mg/ kg bodyweight, the test material produced some evidence of toxicity in the rat. The LD50 for both sexes combined is estimated to be in excess of 2000 mg/kg.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- The available information as a whole meets the tonnage driven information requirements of REACH.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute Oral Toxicity:
1. Eq. to EU Method B.1, 1992 : Read-Across - SOURCE (4-methyl-2-phenyltetrahydro-2H-pyran): The study was performed according to a method equivalent to EU Method B.1 and/or OECD TG 401 guidelines in accordance with GLP. The test material was administered as a single oral dose, by gavage, at a dose level of 2000 mg/kg bodyweight to a group of 5 male and 5 female rats following an overnight fast. The animals were observed for 14 days and survivors were then euthanized. All animals were subject to necropsy. One female was humanely euthanized as death was considered to be inevitable; all remaining animals survived to the end of the study. Clinical signs of toxicity were noted in most animals on the day of dosing, but all surviving animals appeared outwardly healthy from day 3 onwards. There was no adverse effect on bodyweight gain in animals of either sex. Necropsy findings were of low incidence and are considered not to be significant. When administered as a single oral dose of 2000 mg/ kg bodyweight, the test material produced some evidence of toxicity in the rat. The LD50 for both sexes combined is estimated to be in excess of 2000 mg/kg.
Justification for classification or non-classification
The substance does not meet classification criteria under Regulation (EC) No 1272/2008 for acute toxicity.
The weight of evidence based on read-across to analogue substances; via the oral route indicates that the substance cannot be expected to produce acute toxicity sufficient for classification and labelling under the EU criteria at category 4 levels. The substance would be expected to be classified in GHS category 5 levels with an expected LD50 of > 2000 and < 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.